Pentobarbital Can Be Given Intramuscularly
Yes, pentobarbital is approved for intramuscular administration. The FDA-approved drug label explicitly states that pentobarbital sodium injection is "For Intravenous or Intramuscular Use" 1.
Routes of Administration
Pentobarbital sodium injection is formulated as a sterile solution containing 50 mg/mL that can be administered via two routes 1:
- Intravenous (IV) - Primary route
- Intramuscular (IM) - Alternative route
Important caveat: The drug label specifically warns that "This solution is not suitable for subcutaneous administration" 1.
Clinical Context and Evidence
Pediatric Sedation Practice
While the available guideline evidence from emergency department pediatric sedation studies predominantly describes intravenous administration 2, with one study using oral pentobarbital 2, the absence of IM use in these specific studies reflects clinical preference for painless diagnostic procedures rather than a contraindication to IM administration.
The guideline literature reviewed 11 studies where "pentobarbital was given intravenously, except in 1 study in which it was given orally" 2. This pattern likely reflects that:
- IV access provides more predictable pharmacokinetics for procedural sedation
- Painless procedures (CT/MRI scans) don't require the IM route
- The studies focused on ED sedation protocols rather than all possible routes
Comparison with Similar Barbiturate (Methohexital)
The same guidelines document that methohexital, a related barbiturate, has been successfully used via intramuscular route with 92% efficacy for CT scan completion 2. This supports the viability of IM administration for barbiturates in clinical practice.
Real-World IM Use
Research evidence confirms actual intramuscular use of pentobarbital:
- A canine stroke model study administered 15-20 mg/kg pentobarbital intramuscularly 1 hour post-occlusion 3
- A rabbit euthanasia study used 40 mg/kg ketamine and 50 μg/kg dexmedetomidine intramuscularly into the lumbar muscles 4
- A suicide attempt case involved intramuscular injection of pentobarbital sodium into the rectus abdominis muscle 5
Practical Considerations
When IM administration is necessary:
- Ensure proper injection technique to avoid subcutaneous placement
- Expect slower onset compared to IV route
- Monitor for local tissue reactions at injection site
- Be aware that absorption may be less predictable than IV administration
The FDA approval for IM use makes this a legitimate route when IV access is difficult or unavailable, though IV remains the preferred route for most clinical scenarios requiring rapid, predictable sedation.